Basic versus functional inspiratory muscle training for people with COPD
Official title: Early Effects of Different Inspiratory Muscle Training on Disease Clinical Course, Respiratory Parameters, Functional Capacity and Quality of Life in Patients With COPD
Run by University of Yalova · NCT07406659 · Data updated 2026-11-12
This trial will test whether basic or functional inspiratory muscle training helps people with COPD breathe easier and improve exercise ability.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 51 (estimated) |
| Sponsor | University of Yalova Academic / other |
| Locations | 1 site (Yalova, Yalova) |
| Status | Recruiting |
| Started | March 11, 2026 |
| Main results expected | October 1, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | March 16, 2026 |
| Trial ID | NCT07406659 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with COPD diagnosed by GOLD criteria who are clinically stable (no exacerbation in the last month), can walk independently, and can participate voluntarily.
✕Probably not a fit
Patients experiencing a recent COPD exacerbation or those with uncontrolled heart disease, uncontrolled hypertension, or orthopedic/neurological conditions that prevent participation may not benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, single-center experimental study comparing basic inspiratory muscle training (IMT), functional inspiratory muscle training (F-IMT), and a control group in people with COPD. Fifty-one participants meeting GOLD diagnostic criteria and without an acute exacerbation in the prior month will be enrolled at Yalova Training and Research Hospital. Interventions will focus on respiratory muscle exercises delivered as basic IMT or F-IMT, with outcomes including respiratory muscle strength, dyspnea, exercise capacity, and early-term functional changes. The aim is to determine which training approach produces greater short-term improvements in symptoms and functional performance.
Why it matters
Potential benefit: If successful, the training could reduce breathlessness, strengthen respiratory muscles, and improve exercise tolerance for people with COPD.
How similar studies have gone: Conventional inspiratory muscle training has prior evidence for improving muscle strength and dyspnea, while functional IMT is a newer approach with limited published data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Having a COPD diagnosis according to GOLD criteria Having not had an acute exacerbation within the last month Being able to walk independently Having no communication problems Voluntarily participating in the study Exclusion Criteria: Being in a COPD exacerbation Having an orthopedic or neurological disease that would prevent assessment and treatment Having uncontrolled hypertension and heart disease
Where it's running
-
Yalova University
Yalova, Yalova, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Erdi KAYABINAR, PhD — University of Yalova
- Study coordinator: Erdi KAYABINAR, PhD
- Email: erdikayabinar@gmail.com
- Phone: +905077692025
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Flutter therapy added to chest physiotherapy after CABG in COPD patients
This study tests whether adding Flutter therapy to standard chest physiotherapy helps post-CABG patients with mild-to-moderate COPD improve breathing more than chest physiotherapy alone.
-
TPB-based cadence exercise and breathing training for COPD patients
A TPB-based program tests whether breathing training, cadence-guided walking, or both can improve lung function, exercise capacity, and quality of life in adults with COPD.
-
See how dynamic chest X-rays relate to COPD patterns and progression risk
This study looks at existing dynamic chest radiography data to see if new imaging measurements can identify COPD patterns, gauge severity, and predict who may experience faster progression.
-
Personalized mobile app warnings to reduce COPD flares
A personalized mobile app tests whether providing temperature-related risk warnings and protective tips, in addition to usual COPD care, can lower COPD flare-ups over 12 months.
-
CLEAR model to predict when people with severe COPD can be taken off ventilatory support
This project will see if the CLEAR model can predict which adults with severe COPD on invasive or non‑invasive ventilation can be safely taken off ventilatory support.
-
Long-term safety of Tozorakimab in COPD patients with prior exacerbations
This study tests two long-term dosing regimens of tozorakimab in people with COPD who have a history of flare-ups and who completed earlier studies.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.